CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-10 | Zummo Jacqueline Chf Scientific Operations Off | Shares withheld for taxes | −5,225 | $3.00 | $16K | 71,573 |
| 2023-01-10 | Shefferman Jesse CEO and President | Shares withheld for taxes | −5,855 | $3.00 | $18K | 866,982 |
| 2023-01-10 | Bandari Jathin Chief Medical Officer | Shares withheld for taxes | −1,876 | $3.00 | $6K | 18,442 |
| 2023-01-03 | Zummo Jacqueline Chf Scientific Operations Off | Shares withheld for taxes | −2,159 | $2.80 | $6K | 76,798 |
| 2023-01-03 | Shefferman Jesse CEO and President | Shares withheld for taxes | −6,604 | $2.80 | $18K | 872,837 |
| 2023-01-03 | Fry Hannah VP, Controller | Shares withheld for taxes | −361 | $2.80 | $1K | 27,239 |
| 2022-12-30 | Opaleye Management Inc. 10% owner | Sale | +13,173 | $2.71 | $36K | 2,562,594 |
| 2022-12-30 | Opaleye Management Inc. 10% owner | Sale | +2,300 | $2.71 | $6K | 130,000 |
| 2022-09-15 | Opaleye Management Inc. 10% owner | Purchase | +5,000 | $3.80 | $19K | 2,575,777 |
| 2022-09-15 | Opaleye Management Inc. 10% owner | Purchase | +2,300 | $3.80 | $9K | 132,300 |
| 2022-09-14 | Opaleye Management Inc. 10% owner | Purchase | +14,100 | $3.98 | $56K | 2,570,777 |
| 2022-09-14 | Opaleye Management Inc. 10% owner | Purchase | +2,500 | $3.98 | $10K | 130,000 |
| 2022-08-11 | Shefferman Jesse CEO and President | Purchase | +9,065 | $3.84 | $35K | 879,441 |
| 2022-07-16 | Fry Hannah VP, Controller | Grant or award | +25,000 | 27,600 | ||
| 2022-07-15 | Davis Blaine Chief Financial Officer | Shares withheld for taxes | −5,081 | $3.13 | $16K | 20,662 |
| 2022-07-01 | Bandari Jathin Chief Medical Officer | Shares withheld for taxes | −682 | $3.22 | $2K | 20,318 |
| 2022-06-30 | BESHAR LUKE M Director | Purchase | +10,000 | $3.10 | $31K | 198,000 |
| 2022-06-08 | Huang Jane Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-06-08 | Flannelly Barry P Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-06-08 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 9 of 17 · 335 trades